Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCNF | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | ZNF554 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | CCDC74B | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | XKR7 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | FLVCR1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | BRD1 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | EWSR1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | MFSD13A | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | RPAIN | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |